Understanding International Medical Device Cybersecurity Guidance

As connected medical devices become increasingly common — in hospitals, clinics, and home environments — cybersecurity expectations are expanding across global regulatory frameworks.

This whitepaper analyzes and compares four key premarket guidance documents from the U.S. FDA, Health Canada, Australia’s Therapeutic Goods Administration (TGA), and France’s ANSM, highlighting both shared principles and region-specific differences.

The analysis maps over 70 unique requirements across these jurisdictions to help medical device manufacturers (MDMs) understand how to align cybersecurity design and documentation for global market readiness.

Medical device manufacturers can no longer design for a single market. With connected devices deployed worldwide, teams must navigate different cybersecurity expectations across regulators while balancing compliance, cost, and interoperability.

This paper helps manufacturers:

• Identify overlapping requirements that can streamline multi-region submissions.
• Understand where expectations diverge (e.g., firmware authentication, encryption standards, or clinician education).
• Build a unified cybersecurity-by-design strategy that satisfies both FDA and international regulators.
• By harmonizing global requirements early, MDMs can reduce rework, accelerate approvals, and build security into devices from concept through postmarket.